Membranous Nephropathy Clinical Trial
Official title:
A Phase 1b/2a Study of VB119 in Adult Subjects With Primary Membranous Nephropathy
This study is a Phase 1b/2a, open-label, sequential-cohort, dose escalation, and dose expansion study to evaluate the safety, tolerability, PK, and PD of VB119 in subjects with primary MN
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04095156 -
Autoreactive B Cells in Membranous Nephropathy
|
||
| Not yet recruiting |
NCT06341205 -
Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX)
|
Phase 3 | |
| Active, not recruiting |
NCT04893096 -
MOR202 for Refractory MN
|
Phase 2 | |
| Completed |
NCT00405340 -
Rituximab in the Treatment of Idiopathic Membranous Nephropathy
|
Phase 0 | |
| Recruiting |
NCT06065852 -
National Registry of Rare Kidney Diseases
|
||
| Recruiting |
NCT03929887 -
KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis
|
||
| Active, not recruiting |
NCT03949855 -
Belimumab With Rituximab for Primary Membranous Nephropathy
|
Phase 2 | |
| Not yet recruiting |
NCT06242327 -
An Outcome Analysis of Primary Membranous Nephropathy
|
||
| Completed |
NCT00983034 -
The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy
|
N/A | |
| Completed |
NCT03025828 -
Adrenocorticotropic Hormone in Membranous Nephropathy
|
Phase 4 | |
| Recruiting |
NCT05732402 -
An Open-label Study of Povetacicept (ALPN-303) in Autoimmune Kidney Diseases
|
Phase 1/Phase 2 | |
| Enrolling by invitation |
NCT04571658 -
NEPTUNE Match Study
|
||
| Active, not recruiting |
NCT05894512 -
Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy
|
||
| Not yet recruiting |
NCT05941845 -
Interferon Alfa Therapy Based on Th17 Profile in Membranous Nephropathy
|
Phase 2 | |
| Completed |
NCT00518219 -
To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN)
|
Phase 4 | |
| Completed |
NCT02199145 -
Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy
|
N/A | |
| Not yet recruiting |
NCT04326218 -
Immunopathological Analysis in a French National Cohort of Membranous Nephropathy
|
N/A | |
| Active, not recruiting |
NCT03453619 -
Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies
|
Phase 2 | |
| Completed |
NCT01955187 -
Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy
|
Phase 3 | |
| Completed |
NCT04733040 -
Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) (NewPLACE)
|
Phase 2 |